肺鳞状细胞癌-话题@MedSci

#肺鳞状细胞癌#

11篇内容 | 812人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2198825, encodeId=7184219882535, content=<a href='/topic/show?id=2eb682395fd' target=_blank style='color:#2F92EE;'>#肺鳞状细胞癌#</a> <a href='/topic/show?id=029e2901e8e' target=_blank style='color:#2F92EE;'>#免疫微环境#</a>, objectTitle=论文解读｜Hua Jiang/Denggang Fu/Jueping Feng教授团队揭示肺鳞状细胞癌肿瘤免疫微环境的新见解, objectType=article, longId=821704, objectId=cd85821e0474, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-conference-P42ZDP5.jpg, objectUrl=/article/show_article.do?id=cd85821e0474, replyNumber=0, likeNumber=0, createdTime=2024-04-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=cd85821e0474, moduleTitle=论文解读｜Hua Jiang/Denggang Fu/Jueping Feng教授团队揭示肺鳞状细胞癌肿瘤免疫微环境的新见解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd85821e0474)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2184674, encodeId=596a21846e47d, content=<a href='/topic/show?id=d4b161e3515' target=_blank style='color:#2F92EE;'>#林奇综合征#</a> <a href='/topic/show?id=2eb682395fd' target=_blank style='color:#2F92EE;'>#肺鳞状细胞癌#</a> <a href='/topic/show?id=a8ec122803c' target=_blank style='color:#2F92EE;'>#MSI#</a>, objectTitle=林奇综合征应重视MSI检测，竟有患者确诊MSI肺鳞癌, objectType=article, longId=811469, objectId=2f11811469ce, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-signing-contract-V6EFLDM.jpg, objectUrl=/article/show_article.do?id=2f11811469ce, replyNumber=0, likeNumber=22, createdTime=2024-01-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2f11811469ce, moduleTitle=林奇综合征应重视MSI检测，竟有患者确诊MSI肺鳞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f11811469ce)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2173037, encodeId=8f5c21e303708, content=<a href='/topic/show?id=211e823029d' target=_blank style='color:#2F92EE;'>#肺腺癌#</a> <a href='/topic/show?id=2eb682395fd' target=_blank style='color:#2F92EE;'>#肺鳞状细胞癌#</a> <a href='/topic/show?id=e895822947f' target=_blank style='color:#2F92EE;'>#肺肿瘤#</a> <a href='/topic/show?id=4f611082501c' target=_blank style='color:#2F92EE;'>#肺大细胞#</a>, objectTitle=病理干货 | 肺肿瘤的病理诊断思路, objectType=article, longId=803684, objectId=c44d803684bf, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/lung-cancer-s8-lung-cancer-stages.jpg, objectUrl=/article/show_article.do?id=c44d803684bf, replyNumber=0, likeNumber=27, createdTime=2023-12-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c44d803684bf, moduleTitle=病理干货 | 肺肿瘤的病理诊断思路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c44d803684bf)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1672092, encodeId=453716e20923a, content=<a href='/topic/show?id=2eb682395fd' target=_blank style='color:#2F92EE;'>#肺鳞状细胞癌#</a>, objectTitle=BMC Cancer：真实世界研究比较二线afatinib (阿法替尼)对比化疗治疗一线化疗后进展的晚期肺鳞状细胞癌患者的疗效, objectType=article, longId=291850, objectId=7bef291850d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bef291850d8, replyNumber=0, likeNumber=25, createdTime=2022-09-21, rootId=0, userName=zsyan, userId=4dfc26872821, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bef291850d8, moduleTitle=BMC Cancer：真实世界研究比较二线afatinib (阿法替尼)对比化疗治疗一线化疗后进展的晚期肺鳞状细胞癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bef291850d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672091, encodeId=c90b16e2091df, content=<a href='/topic/show?id=2eb682395fd' target=_blank style='color:#2F92EE;'>#肺鳞状细胞癌#</a>, objectTitle=Cancer Commun：紫杉醇脂质体+顺铂vs 吉西他滨+顺铂一线治疗局部晚期或转移性肺鳞状细胞癌的疗效：多中心随机对照研究, objectType=article, longId=219626, objectId=89d3219626c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89d3219626c9, replyNumber=0, likeNumber=32, createdTime=2022-10-10, rootId=0, userName=zsyan, userId=4dfc26872821, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89d3219626c9, moduleTitle=Cancer Commun：紫杉醇脂质体+顺铂vs 吉西他滨+顺铂一线治疗局部晚期或转移性肺鳞状细胞癌的疗效：多中心随机对照研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89d3219626c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672090, encodeId=02df16e209027, content=<a href='/topic/show?id=2eb682395fd' target=_blank style='color:#2F92EE;'>#肺鳞状细胞癌#</a>, objectTitle=Nature：袁刚等发现，NSD3组蛋白甲基化活性升高促使肺鳞状细胞癌发生 , objectType=article, longId=206770, objectId=8ea4206e70ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ea4206e70ca, replyNumber=0, likeNumber=38, createdTime=2021-12-04, rootId=0, userName=zsyan, userId=4dfc26872821, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ea4206e70ca, moduleTitle=Nature：袁刚等发现，NSD3组蛋白甲基化活性升高促使肺鳞状细胞癌发生 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ea4206e70ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672088, encodeId=a8f816e2088cb, content=<a href='/topic/show?id=2eb682395fd' target=_blank style='color:#2F92EE;'>#肺鳞状细胞癌#</a>, objectTitle=Thorax：基于5种蛋白质的标签可以改善可切除肺鳞状细胞癌TNM分期的预后性能, objectType=article, longId=154375, objectId=20101543e581, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20101543e581, replyNumber=0, likeNumber=30, createdTime=2019-04-17, rootId=0, userName=zsyan, userId=4dfc26872821, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20101543e581, moduleTitle=Thorax：基于5种蛋白质的标签可以改善可切除肺鳞状细胞癌TNM分期的预后性能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20101543e581)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672087, encodeId=7ec816e208768, content=<a href='/topic/show?id=2eb682395fd' target=_blank style='color:#2F92EE;'>#肺鳞状细胞癌#</a>, objectTitle=NEJM：肺鳞状细胞癌-病例报道, objectType=article, longId=148774, objectId=3351148e74e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3351148e74e2, replyNumber=0, likeNumber=36, createdTime=2019-06-15, rootId=0, userName=zsyan, userId=4dfc26872821, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3351148e74e2, moduleTitle=NEJM：肺鳞状细胞癌-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3351148e74e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672089, encodeId=541916e20895d, content=<a href='/topic/show?id=2eb682395fd' target=_blank style='color:#2F92EE;'>#肺鳞状细胞癌#</a>, objectTitle=CLIN CANCER RES：PI3K和CDK4/6联合抑制治疗PIK3CA突变肺鳞状细胞癌, objectType=article, longId=156162, objectId=125715616238, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=125715616238, replyNumber=0, likeNumber=28, createdTime=2019-08-26, rootId=0, userName=zsyan, userId=4dfc26872821, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=125715616238, moduleTitle=CLIN CANCER RES：PI3K和CDK4/6联合抑制治疗PIK3CA突变肺鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=125715616238)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672086, encodeId=314816e2086a8, content=<a href='/topic/show?id=2eb682395fd' target=_blank style='color:#2F92EE;'>#肺鳞状细胞癌#</a>, objectTitle=Sci Rep：肺鳞状细胞癌中神经营养酪氨酸激酶受体TrkA及其配体NGF增多, objectType=article, longId=139264, objectId=17b91392643a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17b91392643a, replyNumber=0, likeNumber=36, createdTime=2018-12-27, rootId=0, userName=zsyan, userId=4dfc26872821, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17b91392643a, moduleTitle=Sci Rep：肺鳞状细胞癌中神经营养酪氨酸激酶受体TrkA及其配体NGF增多, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17b91392643a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672085, encodeId=b4e016e208538, content=<a href='/topic/show?id=2eb682395fd' target=_blank style='color:#2F92EE;'>#肺鳞状细胞癌#</a>, objectTitle=PeerJ：从TCGA挖掘信息，寻找肺鳞状细胞癌诊断的生物标志物, objectType=article, longId=122456, objectId=a45a12245624, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a45a12245624, replyNumber=0, likeNumber=31, createdTime=2018-02-15, rootId=0, userName=zsyan, userId=4dfc26872821, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a45a12245624, moduleTitle=PeerJ：从TCGA挖掘信息，寻找肺鳞状细胞癌诊断的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a45a12245624)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672084, encodeId=0bf016e2084ed, content=<a href='/topic/show?id=2eb682395fd' target=_blank style='color:#2F92EE;'>#肺鳞状细胞癌#</a>, objectTitle=Chest：肺叶切除术的时机对临床ⅠA期肺鳞状细胞癌生存率的影响, objectType=article, longId=108757, objectId=c67a108e575c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c67a108e575c, replyNumber=0, likeNumber=32, createdTime=2018-05-23, rootId=0, userName=zsyan, userId=4dfc26872821, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c67a108e575c, moduleTitle=Chest：肺叶切除术的时机对临床ⅠA期肺鳞状细胞癌生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c67a108e575c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672082, encodeId=2a5016e208267, content=<a href='/topic/show?id=2eb682395fd' target=_blank style='color:#2F92EE;'>#肺鳞状细胞癌#</a>, objectTitle=Lancet：阿法替尼适合肺鳞状细胞癌患者的二线治疗方案, objectType=article, longId=52963, objectId=e4a5529632f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4a5529632f, replyNumber=0, likeNumber=30, createdTime=2016-02-28, rootId=0, userName=zsyan, userId=4dfc26872821, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4a5529632f, moduleTitle=Lancet：阿法替尼适合肺鳞状细胞癌患者的二线治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4a5529632f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672083, encodeId=5a5216e20832e, content=<a href='/topic/show?id=2eb682395fd' target=_blank style='color:#2F92EE;'>#肺鳞状细胞癌#</a>, objectTitle=难治性肺鳞状细胞癌患者接受阿法替尼治疗后的生存期优于特罗凯, objectType=article, longId=56751, objectId=154056e51aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=154056e51aa, replyNumber=0, likeNumber=25, createdTime=2016-05-24, rootId=0, userName=zsyan, userId=4dfc26872821, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=154056e51aa, moduleTitle=难治性肺鳞状细胞癌患者接受阿法替尼治疗后的生存期优于特罗凯, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=154056e51aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肺鳞状细胞癌

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肺鳞状细胞癌# #免疫微环境#

论文解读｜Hua Jiang/Denggang Fu/Jueping Feng教授团队揭示肺鳞状细胞癌肿瘤免疫微环境的新见解

2024-04-16发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#林奇综合征# #肺鳞状细胞癌# #MSI#

林奇综合征应重视MSI检测，竟有患者确诊MSI肺鳞癌

2024-01-29发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肺腺癌# #肺鳞状细胞癌# #肺肿瘤# #肺大细胞#

病理干货 | 肺肿瘤的病理诊断思路

2023-12-05发表于上海

zsyan (审核中...)

前往app查看评论内容

#肺鳞状细胞癌#

BMC Cancer：真实世界研究比较二线afatinib (阿法替尼)对比化疗治疗一线化疗后进展的晚期肺鳞状细胞癌患者的疗效

2022-09-21

zsyan (审核中...)

前往app查看评论内容

#肺鳞状细胞癌#

Cancer Commun：紫杉醇脂质体+顺铂vs 吉西他滨+顺铂一线治疗局部晚期或转移性肺鳞状细胞癌的疗效：多中心随机对照研究

2022-10-10

zsyan (审核中...)

前往app查看评论内容

#肺鳞状细胞癌#

Nature：袁刚等发现，NSD3组蛋白甲基化活性升高促使肺鳞状细胞癌发生

2021-12-04

zsyan (审核中...)

前往app查看评论内容

#肺鳞状细胞癌#

Thorax：基于5种蛋白质的标签可以改善可切除肺鳞状细胞癌TNM分期的预后性能

2019-04-17

zsyan (审核中...)

前往app查看评论内容

#肺鳞状细胞癌#

NEJM：肺鳞状细胞癌-病例报道

2019-06-15

zsyan (审核中...)

前往app查看评论内容

#肺鳞状细胞癌#

CLIN CANCER RES：PI3K和CDK4/6联合抑制治疗PIK3CA突变肺鳞状细胞癌

2019-08-26

zsyan (审核中...)

前往app查看评论内容

#肺鳞状细胞癌#

Sci Rep：肺鳞状细胞癌中神经营养酪氨酸激酶受体TrkA及其配体NGF增多

2018-12-27

zsyan (审核中...)

前往app查看评论内容

#肺鳞状细胞癌#

PeerJ：从TCGA挖掘信息，寻找肺鳞状细胞癌诊断的生物标志物

2018-02-15

zsyan (审核中...)

前往app查看评论内容

#肺鳞状细胞癌#

Chest：肺叶切除术的时机对临床ⅠA期肺鳞状细胞癌生存率的影响

2018-05-23

zsyan (审核中...)

前往app查看评论内容

#肺鳞状细胞癌#

Lancet：阿法替尼适合肺鳞状细胞癌患者的二线治疗方案

2016-02-28

zsyan (审核中...)

前往app查看评论内容

#肺鳞状细胞癌#

难治性肺鳞状细胞癌患者接受阿法替尼治疗后的生存期优于特罗凯

2016-05-24

科室
- - 订阅+
  - 更多科室
工具
服务